2025 · Lu — Dietary addition of magnesium hydride nanoparticles: a breakthrough in combating high-fat diet-induced chronic kidney disease.
Super-Abstract
A high-fat diet gradually damages the kidneys — and feeding mice magnesium hydride (MgH₂) nanoparticles, which release hydrogen gas continuously in the digestive tract, provided significant protection against this kidney damage by reducing fibrosis and inflammation. The study identifies a specific molecular pathway (TGF-β/Smad2/3 inhibition via PTEN upregulation) as the mechanism. This is an animal and cell study — the results are not directly transferable to humans. (Medical Gas Research, 2025.)
Commentary
Dyslipidaemia (abnormal blood fat levels) and chronic kidney disease (CKD) are deeply interlinked; renal fibrosis is the common endpoint of progressive CKD regardless of cause. This paper tests MgH₂ nanoparticles added to food — an interesting delivery strategy because MgH₂ reacts with gastric fluid to continuously release H₂ into the digestive tract, unlike inhalation or hydrogen-rich water which provide more intermittent exposure. The 12-week high-fat diet model produced elevated creatinine and urea (kidney damage markers) and renal fibrosis in mice. MgH₂-fortified feed reversed these effects. The mechanism proposed — PTEN upregulation → TGF-β/Smad2/3 inhibition → reduced fibrosis — is well-established in renal biology. The additional Hes1 finding (overexpression negates MgH₂ benefits) adds upstream regulatory detail. The in-vitro HK-2 cell data support the in-vivo findings. All of this is preclinical; human CKD involves much greater complexity (genetic, metabolic, inflammatory, and pharmacological co-factors) that a murine high-fat diet model cannot fully capture.
Key quotes
- „A 12-week high-fat diet significantly elevated the serum urea and creatinine levels in mice. In contrast, dietary addition of magnesium hydride demonstrated a notable protective effect against pathological conditions.“ — key animal outcome: MgH₂-fortified feed reverses kidney damage markers from high-fat diet
- „magnesium hydride functions as a safe and effective hydrogen source capable of inhibiting the activation of the transforming growth factor-beta/Smad2/3 and protein kinase B/mechanistic target of rapamycin pathways by increasing the expression of phosphatase and tensin homologue deleted on chromosome 10.“ — proposed molecular mechanism: PTEN-mediated inhibition of fibrotic and mTOR signalling
- „overexpression of Hes family BHLH transcription factor 1 can negate the beneficial effects of magnesium hydride, suggesting that Hes family BHLH transcription factor 1 may serve as an upstream regulatory target.“ — Hes1 as a potential upstream regulator — negating MgH₂ effects when overexpressed
Our assessment
A mechanistically thorough preclinical study making a case for dietary MgH₂ nanoparticles as a kidney-protective agent in fat-diet-induced CKD. The identification of the PTEN/TGF-β/Smad2/3 pathway and the additional Hes1 regulatory layer add scientific depth. Decisive limitation: this is animal and cell research — findings cannot be directly applied to humans with CKD. The high-fat diet model does not replicate the full complexity of human CKD (which includes diabetic nephropathy, hypertensive nephropathy, glomerulonephritis, etc.). MgH₂ nanoparticle safety in long-term human oral use has not been established. Clinical trials in humans are an essential prerequisite before any treatment relevance can be claimed.
Study design
- Type: animal study + in-vitro (preclinical) · Model: high-fat diet murine CKD model (12 weeks) + HK-2 human kidney proximal tubule cell line · H₂ delivery: MgH₂-fortified feed — continuous H₂ release via Mg-water reaction in the digestive tract
- Endpoints: serum urea and creatinine (kidney function), renal fibrosis histology, PTEN/TGF-β/Smad2/3/mTOR pathway expression, Hes1 overexpression experiment
- Result: MgH₂ feed reversed serum kidney markers and renal fibrosis vs. high-fat diet controls; PTEN upregulation confirmed as mechanism; Hes1 overexpression abolished MgH₂ benefits
Abstract
A substantial body of evidence indicates a positive correlation between dyslipidemia and an elevated risk of chronic kidney disease, with renal interstitial fibrosis frequently serving as a common pathway in the advanced stages of chronic kidney disease progression. Hydrogen has anti-inflammatory and antioxidant properties, and magnesium hydride nanoparticle is a material with high hydrogen storage capacity. Magnesium hydride -fortified feed is capable of releasing hydrogen gas steadily and continuously within the digestive tract. A 12-week high-fat diet significantly elevated the serum urea and creatinine levels in mice. In contrast, dietary addition of magnesium hydride demonstrated a notable protective effect against pathological conditions. Additionally, magnesium hydride -fortified feed was found to reduce renal fibrosis and thereby improve renal function. In support of these findings, an in vitro study utilizing human kidney cortical proximal tubule epithelial cells (HK-2 cells) exposed to palmitic acid under conditions mimicking a high-fat diet confirmed the renoprotective effects of magnesium hydride. Furthermore, the primary target phosphatase and tensin homologue deleted on chromosome 10 and the molecular mechanisms underlying the effects of magnesium hydride, specifically its ability to inhibit the transforming growth factor-beta -Smad family member 2 and 3 (Smad2/3) axis through downregulating the expression of phosphatase and tensin homologue deleted on chromosome 10, were elucidated. Additionally, overexpression of Hes family BHLH transcription factor 1 can negate the beneficial effects of magnesium hydride, suggesting that Hes family BHLH transcription factor 1 may serve as an upstream regulatory target in the context of the effects of magnesium hydride. In conclusion, this study demonstrated that magnesium hydride functions as a safe and effective hydrogen source capable of inhibiting the activation of the transforming growth factor-beta/Smad2/3 and protein kinase B/mechanistic target of rapamycin pathways by increasing the expression of phosphatase and tensin homologue deleted on chromosome 10. This mechanism counteracts the progression of high-fat diet-induced chronic renal damage.
Source & links
Screenshot of the PubMed page
This page mirrors the published abstract (© the authors / publisher) for reference and citation. The canonical source is the PubMed record linked above. This is not medical advice.